21.11.21|CTech"Israel is well known as one of the world’s centers of medical innovation and MEDX’s senior management has a proven track record," said Scott Young, VP of Research at West
01.03.21|Tzally GreenbergThe company aims to raise $100 million in an April IPO, while Pontifax and OrbiMed who previously invested $21 million for a 12.5% stake in ForeBio’s shares are expected to make a $120 million profit
22.02.21|James SpiroThe Nasdaq-traded company has developed a drug to treat fatty liver
12.02.21|Yafit OvadiaThrough advancing experimentation in suborbital conditions, the company is laying the groundwork for future off-planet production
10.02.21|Sophie ShulmanThe Israeli pharmaceutical company concluded the quarter with $4.5 billion in revenues, bringing it to a total of $16.6 billion for 2020
31.12.20|CTechSilicon Valley investor Steve Krawczyk talks to Michael Matias about the importance of grabbing opportunities, how patents play out in the pharma industry, and his role as an “emotional support angel”
14.10.20|ReutersThe company said it was expanding manufacturing capabilities for opaganib, its experimental cancer drug for which it intends to apply for emergency use in Covid-19 patients
22.09.20|Meir OrbachThe agreement provides JuveStar with exclusive rights to develop and commercialize Raziel Therapeutics’ proprietary RZL-012 compound
23.08.20|CTechMicrofluidic chips that simulate human tissue enable us to conduct medical experiments in ways that could not have been even imagined only a few years ago. Two leading Israeli researchers report from the turbulent Israeli front line of the global 'organ-on-a-chip' sector
18.08.20|CTech and Sophie ShulmanThe Department of Justice accuses Israeli drugmaker of using kickbacks to boost sales of its multiple sclerosis drug Copaxone, as well as causing the submission of false claims to Medicare
10.08.20|Sophie ShulmanGovernments want to be among the first to get their hands on the coveted solution, but they are also risking money that could be used to strengthen their healthcare system
08.08.20|Yoghev CarmelFrom attempts to crack the aging process to developing asthma medicine, the most innovative medical experiments are taking place these days in space
17.06.20|Hagar Ravet“To the best of our knowledge, Kamada is the first company globally to complete manufacturing of a plasma-derived IgG product for the treatment of Covid-19,” says CEO of the Nasdaq listed company
19.12.19|Adi PickThe company's drug is injected into subcutaneous fat where it causes immediate fat cell death at the injection site, resulting in a reduction of fat tissue
20.10.19|Tzally GreenbergThe deal will make Ireland-headquartered Cosmo the largest shareholder of Israel-based Redhill
14.06.19|Daniel Grunstein, Tiran RothmanRidesharing companies promote autonomous and electrified fleets by spending billions on attracting loyal customers; Life-science companies yield zero revenue and burn millions until treatment safety and efficacy are proved
06.02.19|Tzally GreenbergTeva unveiled a reorganization plan in December 2017 to ameliorate its debilitating debt, announcing its intention to close or sale facilities and layoff 25% of employees by 2019
13.01.19|Lilach BaumerThe Israeli drugmaker agreed to pay $135 million to bring the allegations to rest. 46 other pharmaceutical companies were also named in the suit
08.01.19|Lilach Baumer and Hezi SternlichtSpeaking at J.P. Morgan’s Healthcare Conference on Monday, CEO Kåre Schultz said he expects the U.S. generic market to stabilize in 2019
07.01.19|Amitay Gazit and Dror ReichIsrael's pharmaceutical export fell 21% in 2018, according to a new report. Teva let go around 1,200 Israeli employees last year